To amend the Public Health Service Act to increase the transparency of pharmaceutical research costs, and for other purposes.
Sponsors
Legislative Progress
IntroducedMs. Stabenow (for herself, Ms. Smith, and Mr. Welch) introduced …
Ms. Stabenow (for herself, Ms. Smith, and Mr. Welch) introduced …
Ms. Stabenow (for herself, Ms. Smith, and Mr. Welch) introduced …
Ms. Stabenow (for herself, Ms. Smith, and Mr. Welch) introduced …
Ms. Stabenow (for herself, Ms. Smith, and Mr. Welch) introduced …
Ms. Stabenow (for herself, Ms. Smith, and Mr. Welch) introduced …
Ms. Stabenow (for herself, Ms. Smith, and Mr. Welch) introduced …
Ms. Stabenow (for herself, Ms. Smith, and Mr. Welch) introduced …
Ms. Stabenow (for herself, Ms. Smith, and Mr. Welch) introduced …
Ms. Stabenow (for herself, Ms. Smith, and Mr. Welch) introduced …
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology